BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15766664)

  • 1. DJ-1, a novel regulator of the tumor suppressor PTEN.
    Kim RH; Peters M; Jang Y; Shi W; Pintilie M; Fletcher GC; DeLuca C; Liepa J; Zhou L; Snow B; Binari RC; Manoukian AS; Bray MR; Liu FF; Tsao MS; Mak TW
    Cancer Cell; 2005 Mar; 7(3):263-73. PubMed ID: 15766664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conserved PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila.
    Scanga SE; Ruel L; Binari RC; Snow B; Stambolic V; Bouchard D; Peters M; Calvieri B; Mak TW; Woodgett JR; Manoukian AS
    Oncogene; 2000 Aug; 19(35):3971-7. PubMed ID: 10962553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
    Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
    Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
    J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
    Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
    Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
    Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of cellular apoptotic potential: contributions to oncogenesis.
    Stambolic V; Mak TW; Woodgett JR
    Oncogene; 1999 Nov; 18(45):6094-103. PubMed ID: 10557100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated PTEN-PKB and negative receptor status in human breast cancer.
    Shi W; Zhang X; Pintilie M; Ma N; Miller N; Banerjee D; Tsao MS; Mak T; Fyles A; Liu FF
    Int J Cancer; 2003 Mar; 104(2):195-203. PubMed ID: 12569575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB.
    Stocker H; Andjelkovic M; Oldham S; Laffargue M; Wymann MP; Hemmings BA; Hafen E
    Science; 2002 Mar; 295(5562):2088-91. PubMed ID: 11872800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome.
    Panigrahi AR; Pinder SE; Chan SY; Paish EC; Robertson JF; Ellis IO
    J Pathol; 2004 Sep; 204(1):93-100. PubMed ID: 15307142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drosophila PTEN regulates cell growth and proliferation through PI3K-dependent and -independent pathways.
    Gao X; Neufeld TP; Pan D
    Dev Biol; 2000 May; 221(2):404-18. PubMed ID: 10790335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation.
    Ghosh AK; Grigorieva I; Steele R; Hoover RG; Ray RB
    Gene; 1999 Jul; 235(1-2):85-91. PubMed ID: 10415336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling from Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila melanogaster.
    Miron M; Lasko P; Sonenberg N
    Mol Cell Biol; 2003 Dec; 23(24):9117-26. PubMed ID: 14645523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
    Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
    Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
    Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
    Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
    Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
    Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
    Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.